- Home
- CRNX vs E Comparison
CRNX vs E Comparison
Compare CRNX & E Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRNX
- E
- Stock Information
- Founded
- CRNX 2008
- E 1953
- Country
- CRNX United States
- E Italy
- Employees
- CRNX N/A
- E N/A
- Industry
- CRNX Biotechnology: Pharmaceutical Preparations
- E Oil & Gas Production
- Sector
- CRNX Health Care
- E Energy
- Exchange
- CRNX Nasdaq
- E Nasdaq
- Market Cap
- CRNX 2.8B
- E N/A
- IPO Year
- CRNX 2018
- E 1995
- Fundamental
- Price
- CRNX $30.51
- E $29.56
- Analyst Decision
- CRNX Strong Buy
- E Buy
- Analyst Count
- CRNX 10
- E 5
- Target Price
- CRNX $75.00
- E $31.60
- AVG Volume (30 Days)
- CRNX 942.0K
- E 287.1K
- Earning Date
- CRNX 05-08-2025
- E 07-25-2025
- Dividend Yield
- CRNX N/A
- E 7.73%
- EPS Growth
- CRNX N/A
- E N/A
- EPS
- CRNX N/A
- E 0.83
- Revenue
- CRNX $760,000.00
- E $98,314,958,896.00
- Revenue This Year
- CRNX $343.70
- E N/A
- Revenue Next Year
- CRNX $733.93
- E $2.45
- P/E Ratio
- CRNX N/A
- E $16.30
- Revenue Growth
- CRNX N/A
- E 0.42
- 52 Week Low
- CRNX $24.10
- E $24.65
- 52 Week High
- CRNX $62.53
- E $33.12
- Technical
- Relative Strength Index (RSI)
- CRNX 46.97
- E 53.85
- Support Level
- CRNX $29.05
- E $29.20
- Resistance Level
- CRNX $30.99
- E $29.64
- Average True Range (ATR)
- CRNX 1.43
- E 0.37
- MACD
- CRNX -0.09
- E -0.04
- Stochastic Oscillator
- CRNX 32.27
- E 40.00
About CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.